• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠肿瘤内镜黏膜下剥离术后异时性晚期腺瘤复发的长期风险:一项倾向评分匹配的纵向队列研究及5年随访

The Long-Term Risk of Metachronous Advanced Adenoma Recurrence After Endoscopic Submucosal Dissection for Colorectal Neoplasia: A Propensity-Score Matched Longitudinal Cohort With 5-Year Follow-Up.

作者信息

Dai Min, Xiao Xiang, Guo Cosmos L T, Lui Rashid N, Yip Hon Chi, Chu Simon, Hon Sok Fei, Ng Simon S M, Chiu Philip W Y, Ng Siew C, Chan Francis K L, Lau Louis H S

机构信息

Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.

Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, China.

出版信息

United European Gastroenterol J. 2025 Mar;13(2):210-219. doi: 10.1002/ueg2.12735. Epub 2024 Dec 21.

DOI:10.1002/ueg2.12735
PMID:39707920
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11975625/
Abstract

INTRODUCTION

Long-term data on metachronous advanced adenoma (AA) recurrence after endoscopic submucosal dissection (ESD) remain scarce, leading to a lack of a standardized surveillance strategy. This study aims to evaluate the long-term risk of recurrent AA after ESD.

MATERIALS AND METHODS

A longitudinal retrospective cohort study with propensity-score matching was conducted in a tertiary hospital in Hong Kong. Subjects who underwent colorectal ESD between 2011 and 2017 were enrolled and defined as the post-ESD group. Selected subjects who underwent polypectomy in their index colonoscopy between 2011 and 2017 were enrolled and stratified into the low- intermediate- and the high-risk groups according to the US Multi-Society Task Force (USMSTF) guideline. The risks of recurrent AA were assessed by Cox proportional hazards regression in the matched cohorts.

RESULTS

A total of 1745 subjects were included, with 203 post-ESD subjects fully matched with 729 high-risk and 813 low-intermediate-risk subjects, respectively. The 5-year cumulative incidence of recurrent AA in the post-ESD group was 7.8%. After 5 years, the post-ESD group was not associated with a higher rate of recurrent AA to the low-intermediate-risk group (7.8% vs. 5.5%; adjusted HR [aHR] 1.64, 95% CI 0.77-3.48, p = 0.197) but a lower rate of recurrent AA (7.8% vs. 11.8%; aHR 0.40, 95% CI 0.19-0.85, p = 0.017) than the high-risk group.

CONCLUSION

Subjects who underwent ESD were not associated with an increased 5-year risk of metachronous AA recurrence than low-intermediate or high-risk groups in USMSTF. The findings will inform future guidelines on post-ESD surveillance colonoscopy strategies.

摘要

引言

关于内镜黏膜下剥离术(ESD)后异时性进展性腺瘤(AA)复发的长期数据仍然稀缺,导致缺乏标准化的监测策略。本研究旨在评估ESD后AA复发的长期风险。

材料与方法

在香港一家三级医院进行了一项倾向评分匹配的纵向回顾性队列研究。纳入2011年至2017年间接受结直肠ESD的受试者,并将其定义为ESD后组。选取2011年至2017年间在其初次结肠镜检查时接受息肉切除术的受试者,并根据美国多学会工作组(USMSTF)指南将其分层为低、中、高风险组。通过Cox比例风险回归评估匹配队列中AA复发的风险。

结果

共纳入1745名受试者,其中203名ESD后受试者分别与729名高风险和813名低-中风险受试者完全匹配。ESD后组AA复发的5年累积发病率为7.8%。5年后,ESD后组与低-中风险组相比,AA复发率没有更高(7.8%对5.5%;调整后风险比[aHR]为1.64,95%置信区间为0.77-3.48,p = 0.197),但与高风险组相比,AA复发率较低(7.8%对11.8%;aHR为0.40,95%置信区间为0.19-0.85,p = 0.017)。

结论

与USMSTF定义的低-中风险或高风险组相比,接受ESD的受试者5年内异时性AA复发风险并未增加。这些发现将为未来ESD后监测结肠镜检查策略的指南提供参考。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4520/11975625/58353c5b2425/UEG2-13-210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4520/11975625/b962734dbee2/UEG2-13-210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4520/11975625/1306d537e0e5/UEG2-13-210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4520/11975625/58353c5b2425/UEG2-13-210-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4520/11975625/b962734dbee2/UEG2-13-210-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4520/11975625/1306d537e0e5/UEG2-13-210-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4520/11975625/58353c5b2425/UEG2-13-210-g003.jpg

相似文献

1
The Long-Term Risk of Metachronous Advanced Adenoma Recurrence After Endoscopic Submucosal Dissection for Colorectal Neoplasia: A Propensity-Score Matched Longitudinal Cohort With 5-Year Follow-Up.结直肠肿瘤内镜黏膜下剥离术后异时性晚期腺瘤复发的长期风险:一项倾向评分匹配的纵向队列研究及5年随访
United European Gastroenterol J. 2025 Mar;13(2):210-219. doi: 10.1002/ueg2.12735. Epub 2024 Dec 21.
2
Metachronous Neoplasia and Local Recurrence after Colorectal Endoscopic Submucosal Dissection.
Acta Med Okayama. 2017 Dec;71(6):475-483. doi: 10.18926/AMO/55584.
3
Long-term outcomes after endoscopic submucosal dissection for superficial colorectal tumors.内镜黏膜下剥离术治疗结直肠浅表肿瘤的长期疗效。
Gastrointest Endosc. 2017 Mar;85(3):546-553. doi: 10.1016/j.gie.2016.07.044. Epub 2016 Jul 27.
4
Five-year risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prospective study in 2452 asymptomatic Koreans.根据基线风险分层,首次结肠镜检查后进展性结直肠腺瘤的 5 年风险:2452 例无症状韩国人的前瞻性研究。
Gut. 2011 Nov;60(11):1537-43. doi: 10.1136/gut.2010.232876. Epub 2011 Mar 22.
5
Development and validation of a risk score for advanced colorectal adenoma recurrence after endoscopic resection.内镜切除术后进展期大肠腺瘤复发风险评分的建立与验证
World J Gastroenterol. 2016 Jul 14;22(26):6049-56. doi: 10.3748/wjg.v22.i26.6049.
6
Endoscopic mucosal resection (EMR) versus endoscopic submucosal dissection (ESD) for resection of large distal non-pedunculated colorectal adenomas (MATILDA-trial): rationale and design of a multicenter randomized clinical trial.内镜下黏膜切除术(EMR)与内镜下黏膜下剥离术(ESD)治疗远端大肠广基腺瘤的比较(MATILDA试验):一项多中心随机临床试验的原理与设计
BMC Gastroenterol. 2016 May 26;16(1):56. doi: 10.1186/s12876-016-0468-6.
7
Long-term outcomes of endoscopic submucosal dissection for high-grade dysplasia and early-stage carcinoma in the colorectum.内镜黏膜下剥离术治疗结直肠高级别上皮内瘤变和早期癌的长期疗效。
Cancer Commun (Lond). 2018 Mar 21;38(1):3. doi: 10.1186/s40880-018-0273-4.
8
Propensity score-matched analysis of endoscopic resection for recurrent colorectal neoplasms: A pilot study.复发性结直肠肿瘤内镜切除的倾向评分匹配分析:一项初步研究。
J Gastroenterol Hepatol. 2021 Sep;36(9):2568-2574. doi: 10.1111/jgh.15519. Epub 2021 May 5.
9
Risk factors for metachronous adenoma in the residual colon of patients undergoing curative surgery for colorectal cancer.接受结直肠癌根治性手术患者残留结肠中异时性腺瘤的危险因素。
Int J Colorectal Dis. 2017 Nov;32(11):1609-1616. doi: 10.1007/s00384-017-2881-x. Epub 2017 Aug 21.
10
Using New Hampshire Colonoscopy Registry data to assess United States and European post-polypectomy surveillance guidelines.利用新罕布什尔州结肠镜检查登记数据评估美国和欧洲息肉切除术后监测指南。
Endoscopy. 2023 May;55(5):423-431. doi: 10.1055/a-1970-5377. Epub 2022 Oct 31.

引用本文的文献

1
Defining Optimal Surveillance Intervals Following Post-Colorectal Endoscopic Submucosal Dissection.确定结直肠内镜黏膜下剥离术后的最佳监测间隔
United European Gastroenterol J. 2025 Jun;13(5):669-671. doi: 10.1002/ueg2.12763. Epub 2025 Feb 17.

本文引用的文献

1
Endoscopic En Bloc Versus Piecemeal Resection of Large Nonpedunculated Colonic Adenomas : A Randomized Comparative Trial.内镜整块切除与分片切除大型无蒂结直肠腺瘤的随机对照试验。
Ann Intern Med. 2024 Jan;177(1):29-38. doi: 10.7326/M23-1812. Epub 2023 Dec 12.
2
Gut microbiota in colorectal cancer development and therapy.结直肠癌发生发展及治疗中的肠道菌群
Nat Rev Clin Oncol. 2023 Jul;20(7):429-452. doi: 10.1038/s41571-023-00766-x. Epub 2023 May 11.
3
Third Asia-Pacific consensus recommendations on colorectal cancer screening and postpolypectomy surveillance.
第三届亚太地区结直肠癌筛查与息肉切除术后监测共识建议
Gut. 2022 Nov;71(11):2152-2166. doi: 10.1136/gutjnl-2022-327377. Epub 2022 Aug 24.
4
Long-term Outcomes After Endoscopic Submucosal Dissection for Large Colorectal Epithelial Neoplasms: A Prospective, Multicenter, Cohort Trial From Japan.日本一项前瞻性、多中心队列研究:内镜黏膜下剥离术治疗大肠大型上皮性肿瘤的长期疗效。
Gastroenterology. 2022 Nov;163(5):1423-1434.e2. doi: 10.1053/j.gastro.2022.07.002. Epub 2022 Jul 8.
5
Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022.用于浅表性胃肠道病变的内镜黏膜下剥离术:欧洲胃肠内镜学会(ESGE)指南 - 2022年更新版
Endoscopy. 2022 Jun;54(6):591-622. doi: 10.1055/a-1811-7025. Epub 2022 May 6.
6
AGA Clinical Practice Update on Surveillance After Pathologically Curative Endoscopic Submucosal Dissection of Early Gastrointestinal Neoplasia in the United States: Commentary.AGA 临床实践更新:美国早期胃肠道肿瘤经内镜黏膜下剥离术后的监测:评论。
Gastroenterology. 2021 Dec;161(6):2030-2040.e1. doi: 10.1053/j.gastro.2021.08.058. Epub 2021 Oct 21.
7
Timing of endoscopy for acute upper gastrointestinal bleeding: a territory-wide cohort study.急性上消化道出血内镜检查时机:全港范围队列研究。
Gut. 2022 Aug;71(8):1544-1550. doi: 10.1136/gutjnl-2020-323054. Epub 2021 Sep 21.
8
Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis.基于人群的分析:华法林和直接口服抗凝剂在结肠镜检查后息肉切除术后出血和血栓栓塞的风险。
Gut. 2022 Jan;71(1):100-110. doi: 10.1136/gutjnl-2020-323600. Epub 2021 Feb 22.
9
Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population.临床实践新进展:普通风险人群结直肠癌化学预防。
Gut. 2020 Dec;69(12):2244-2255. doi: 10.1136/gutjnl-2020-320990. Epub 2020 Sep 28.
10
Recommendations for Follow-Up After Colonoscopy and Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer.结肠镜检查和息肉切除术后的随访建议:美国结直肠癌多学会特别工作组的共识更新
Am J Gastroenterol. 2020 Mar;115(3):415-434. doi: 10.14309/ajg.0000000000000544.